Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Michael T. Tetzlaff, Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies, James S. Wilmott, Peter M. Ferguson, Merrick I. Ross, Andrew J. Spillane, Kim Vu, Jianhua Ma, Jing Ning, Lauren E. Haydu, Robyn P.M. Saw, Jennifer A. Wargo, Hussein A. Tawbi, Jeffrey E. Gershenwald, Georgina V. Long, Michael A. Davies, Richard A. Scolyer